Physician profile
Ronald K Olm
NPI 1356344741
$5,714.31
in general payments reported to CMS, 2019-2025
33 companies · $962 in 2025
The $962 reported for 2025 was more than what 79% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $351 · 2021: $535 · 2022: $1,509 · 2023: $987 · 2024: $852 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,657 · Education: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,657.18 |
| Education | $143.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $834.92 | 2022-2025 | |
| Cardiovascular Systems INC. | $697.94 | 2019-2022 | |
| Paragon 28, INC. | $547.89 | 2019-2024 | Grappler |
| Stryker Corporation | $527.49 | 2023-2025 | N/A, Citrefix, Phalinx |
| Abbott Laboratories | $384.85 | 2022-2025 | Diamondback Peripheral, Diamondback Coronary, Proclaim |
| Inari Medical, INC. | $247.25 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Horizon Therapeutics Plc | $213.90 | 2019-2022 | |
| Organogenesis INC. | $208.65 | 2019-2025 | Puraply Wound Matrix, Puraply |
| Kerecis Limited | $192.49 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $171.40 | 2019-2022 | |
| Medline Industries LP | $159.20 | 2022 | |
| Epsfl, LLC | $152.72 | 2023 | |
| Lightbody Medical Technologies INC | $147.79 | 2024 | |
| Pfizer INC. | $145.34 | 2019-2020 | |
| Convatec INC. | $137.16 | 2023-2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biopoly LLC | $116.85 | 2023 | |
| Osteomed LLC | $114.94 | 2020 | |
| Abbvie INC. | $108.45 | 2021-2025 | |
| Bard Peripheral Vascular, INC. | $103.95 | 2022 | |
| Microaire Surgical Instruments LLC | $93.22 | 2022 | |
| Depuy Synthes Sales INC. | $86.06 | 2022 | |
| Nevro Corp. | $47.40 | 2022 | |
| Globus Medical, INC. | $44.33 | 2025 | Senza |
| Kowa Pharmaceuticals America, INC. | $36.17 | 2023 | Seglentis |
| Kci USA, INC. | $35.84 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $31.66 | 2019 | |
| Amgen INC. | $24.24 | 2025 | Krystexxa |
| Medtronic, INC. | $23.78 | 2021 | |
| Paratek Pharmaceuticals, INC. | $18.45 | 2021 | |
| Acumed LLC | $18.32 | 2023 | Inframe Implant, Innate Implant |
| Bioventus LLC | $15.93 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.37 | 2020 | |
| Wright Medical Technology, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Olm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.